Clinical Leader Case Study: Managing myopia with the family

This case is highlights that myopia management decision making includes much more than a child’s refraction. Learn how Keyur Patel involved the parent in the conversation and decision making, to determine the starting myopia management option for now, as well as considering the future.

Clinical Leader Case Study: First myopia correction

Parents can be conservative about childhood contact lens wear, especially if they have no experience of myopia themselves. Read how Bhavin Shah successfully guided parents into embracing MiSight 1 day for their eight-year-old daughter, as her first myopia management strategy.

When to start myopia control

When to start myopia management

Myopia is becoming more common, as knowledge on detection and management increase. When should you start myopia control? Here we present an overview of when you might start myopia management across the spectrum of patient presentations. Since every child and their family are unique, we also point you towards more information for each situation.

A future high myope: diagnosis with axial length

This case study explores clinical data for a 7-year-old child whose refractive error and axial length is changing at an alarming rate. How can we best determine the rate of progression and set our management plans, using axial length?

Managing the non-myopic eye in unilateral myopia

If your patient is a unilateral myope, sometimes the myopic eye is the easier one to manage! This case study explores the options to appropriately diagnose, track and manage the non-myopic eye in a unilateral myope – where the non-myopic eye seems to be progressing faster than the myopic eye treated with orthokeratology.

Orthokeratology lens wear in lagophthalmos

Can a teen with lagophthalmos wear orthokeratology lenses? This case discusses the staining frequency in orthokeratology wear, the impact of lubricant eye drops and lens hygiene processes, and more tips for patient care.

Understanding on and off label prescribing

Understanding on- and off-label prescribing

What does on-label and off-label prescribing mean in myopia management? Here we explore this topic from the point of view of medications and medical devices, what regulatory approvals mean and how this applies to decision making and clinical processes such as informed consent.

Compounded topical atropine: is every bottle the same?

How consistent is compounded topical atropine from bottle-to-bottle? What clinical results could indicate variability? Read more in this clinical case where a miniscule change in concentration gave notably better clinical outcomes.

Pre-myopia and young age: topical atropine or not?

Is a 3-year-old too young for low-dose atropine treatment? What about if they’re a pre-myope? Learn more about balancing proactive management with the research evidence and clinical considerations.

Putting Myopia Management Standard Of Care Into Action

In 2021, the World Council of Optometry (WCO) passed a resolution that publicly declares support for myopia management as standard of care. Since then, CooperVision has supported the WCO to empower eye care professionals to put this into action, with a multilingual online resource launched and more being added throughout 2022. Explore and learn more here.